Birdwatch Note
2025-01-11 02:24:47 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Misleading. While several studies have provided initial evidence suggesting fenbendazole has potential in treating various types of cancer, including pancreatic cancer, further research is needed to determine its success and safety in human clinical trials. https://www.healthline.com/health/pancreatic-cancer/fenbendazole-for-pancreatic-cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC3580766/ https://www.nature.com/articles/s41598-018-30158-6
Written by 7F16863BE3FB87264952B6B64F80825EDA9544AAAC92BB98151CA3A77A7217DC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1877767497358651858
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1877904460858753298
- noteId - 1877904460858753298
- participantId -
- noteAuthorParticipantId - 7F16863BE3FB87264952B6B64F80825EDA9544AAAC92BB98151CA3A77A7217DC Participant Details
- createdAtMillis - 1736562287903
- tweetId - 1877767497358651858
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Misleading. While several studies have provided initial evidence suggesting fenbendazole has potential in treating various types of cancer, including pancreatic cancer, further research is needed to determine its success and safety in human clinical trials. https://www.healthline.com/health/pancreatic-cancer/fenbendazole-for-pancreatic-cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC3580766/ https://www.nature.com/articles/s41598-018-30158-6
Note Ratings
| rated at | rated by | |
| 2025-01-12 04:09:20 -0600 | Rating Details | |
| 2025-01-11 18:26:04 -0600 | Rating Details | |
| 2025-01-11 17:32:49 -0600 | Rating Details | |
| 2025-01-11 15:25:21 -0600 | Rating Details | |
| 2025-01-11 13:48:04 -0600 | Rating Details | |
| 2025-01-11 13:24:25 -0600 | Rating Details | |
| 2025-01-11 11:43:33 -0600 | Rating Details | |
| 2025-01-11 11:15:57 -0600 | Rating Details | |
| 2025-01-11 10:32:24 -0600 | Rating Details | |
| 2025-01-11 09:00:18 -0600 | Rating Details | |
| 2025-01-11 08:47:30 -0600 | Rating Details | |
| 2025-01-11 06:40:35 -0600 | Rating Details | |
| 2025-01-11 06:15:04 -0600 | Rating Details | |
| 2025-01-11 05:44:51 -0600 | Rating Details | |
| 2025-01-11 04:44:42 -0600 | Rating Details | |
| 2025-01-11 03:51:06 -0600 | Rating Details | |
| 2025-01-11 03:41:13 -0600 | Rating Details | |
| 2025-01-11 03:34:10 -0600 | Rating Details | |
| 2025-01-11 02:33:10 -0600 | Rating Details | |
| 2025-01-11 01:25:59 -0600 | Rating Details | |
| 2025-01-11 01:14:52 -0600 | Rating Details | |
| 2025-01-11 00:11:49 -0600 | Rating Details | |
| 2025-01-11 00:08:20 -0600 | Rating Details | |
| 2025-01-11 00:07:40 -0600 | Rating Details | |
| 2025-01-10 23:38:05 -0600 | Rating Details | |
| 2025-01-10 23:31:44 -0600 | Rating Details | |
| 2025-01-10 22:42:38 -0600 | Rating Details | |
| 2025-01-10 22:21:42 -0600 | Rating Details | |
| 2025-01-10 21:54:29 -0600 | Rating Details | |
| 2025-01-10 21:45:53 -0600 | Rating Details | |
| 2025-01-10 21:43:26 -0600 | Rating Details | |
| 2025-01-10 20:57:13 -0600 | Rating Details | |
| 2025-01-10 20:54:10 -0600 | Rating Details | |
| 2025-01-10 20:47:00 -0600 | Rating Details | |
| 2025-01-14 16:14:36 -0600 | Rating Details | |
| 2025-01-14 14:36:46 -0600 | Rating Details | |
| 2025-01-14 13:15:51 -0600 | Rating Details | |
| 2025-01-11 12:26:56 -0600 | Rating Details | |
| 2025-01-11 07:01:33 -0600 | Rating Details | |
| 2025-01-11 01:50:42 -0600 | Rating Details | |
| 2025-01-11 01:10:41 -0600 | Rating Details | |
| 2025-01-10 22:15:58 -0600 | Rating Details | |
| 2025-01-10 20:41:12 -0600 | Rating Details | |
| 2025-01-10 20:36:15 -0600 | Rating Details | |
| 2025-01-13 07:19:45 -0600 | Rating Details | |
| 2025-01-11 14:05:29 -0600 | Rating Details | |
| 2025-01-11 14:00:18 -0600 | Rating Details | |
| 2025-01-11 12:31:25 -0600 | Rating Details | |
| 2025-01-11 11:11:44 -0600 | Rating Details | |
| 2025-01-11 10:44:36 -0600 | Rating Details | |
| 2025-01-11 08:44:18 -0600 | Rating Details | |
| 2025-01-11 07:16:06 -0600 | Rating Details | |
| 2025-01-11 05:13:18 -0600 | Rating Details | |
| 2025-01-11 04:50:12 -0600 | Rating Details | |
| 2025-01-11 01:45:14 -0600 | Rating Details | |
| 2025-01-11 01:22:40 -0600 | Rating Details | |
| 2025-01-11 01:04:49 -0600 | Rating Details | |
| 2025-01-10 21:43:44 -0600 | Rating Details | |
| 2025-01-10 21:20:02 -0600 | Rating Details |